Michael A. Gorin, M.D.
Michael A. Gorin, M.D.
Urology Associates & UPMC Western Maryland, Cumberland, MD
Verified email at urologyassociatesmd.com - Homepage
Title
Cited by
Cited by
Year
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters
KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ...
Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016
4022016
BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants
F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ...
Cancer research 66 (1), 41-45, 2006
2492006
Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry
PM Pierorazio, MH Johnson, MW Ball, MA Gorin, BJ Trock, P Chang, ...
European urology 68 (3), 408-415, 2015
2252015
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations
JJ Tosoian, MA Gorin, AE Ross, KJ Pienta, PT Tran, EM Schaeffer
Nature Reviews Urology 14 (1), 15, 2017
1522017
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ...
European journal of nuclear medicine and molecular imaging 44 (12), 2117-2136, 2017
1442017
Protein kinase Cε: an oncogene and emerging tumor biomarker
MA Gorin, Q Pan
Molecular cancer 8 (1), 1-8, 2009
1432009
PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges
SP Rowe, MA Gorin, ME Allaf, KJ Pienta, PT Tran, MG Pomper, AE Ross, ...
Prostate cancer and prostatic diseases 19 (3), 223-230, 2016
1162016
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
1132020
Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind)
A Khalifeh, JH Kaouk, S Bhayani, C Rogers, M Stifelman, YS Tanagho, ...
The Journal of urology 190 (5), 1674-1679, 2013
1092013
Grade heterogeneity in small renal masses: potential implications for renal mass biopsy
MW Ball, SM Bezerra, MA Gorin, M Cowan, CP Pavlovich, PM Pierorazio, ...
The Journal of urology 193 (1), 36-40, 2015
1002015
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18 F-DCFPyL PET/CT
SP Rowe, MA Gorin, HJ Hammers, MS Javadi, H Hawasli, Z Szabo, ...
Annals of nuclear medicine 29 (10), 877-882, 2015
972015
Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors
MA Gorin, SP Rowe, AS Baras, LB Solnes, MW Ball, PM Pierorazio, ...
European urology 69 (3), 413-416, 2016
862016
Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis
MA Gorin, MW Ball, PM Pierorazio, YS Tanagho, SB Bhayani, JH Kaouk, ...
The Journal of urology 190 (5), 1907-1911, 2013
852013
Pomegranate fruit extract impairs invasion and motility in human breast cancer
GN Khan, MA Gorin, D Rosenthal, Q Pan, LW Bao, ZF Wu, RA Newman, ...
Integrative cancer therapies 8 (3), 242-253, 2009
842009
Development of an automated and sensitive microfluidic device for capturing and characterizing circulating tumor cells (CTCs) from clinical blood samples
P Gogoi, S Sepehri, Y Zhou, MA Gorin, C Paolillo, E Capoluongo, ...
PloS one 11 (1), e0147400, 2016
722016
Factors that influence patient enrollment in active surveillance for low-risk prostate cancer
MA Gorin, CT Soloway, A Eldefrawy, MS Soloway
Urology 77 (3), 588-591, 2011
722011
Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer
SM Pearce, S Golan, MA Gorin, AN Luckenbaugh, SB Williams, JF Ward, ...
European urology 71 (3), 476-482, 2017
702017
Proposal for a structured reporting system for prostate-specific membrane antigen–targeted PET imaging: PSMA-RADS version 1.0
SP Rowe, KJ Pienta, MG Pomper, MA Gorin
Journal of Nuclear Medicine 59 (3), 479-485, 2018
692018
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
N Radwan, R Phillips, A Ross, SP Rowe, MA Gorin, ES Antonarakis, ...
BMC cancer 17 (1), 1-9, 2017
692017
Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk …
MA Gorin, SP Rowe, HD Patel, I Vidal, M Mana-Ay, MS Javadi, LB Solnes, ...
The Journal of urology 199 (1), 126-132, 2018
682018
The system can't perform the operation now. Try again later.
Articles 1–20